These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 15711605

  • 1. Clinical ease of using doxazosin in BPH patients with and without hypertension.
    Steers WD, Kirby RS.
    Prostate Cancer Prostatic Dis; 2005; 8(2):152-7. PubMed ID: 15711605
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension.
    Chung BH, Hong SJ.
    BJU Int; 2006 Jan; 97(1):90-5. PubMed ID: 16336335
    [Abstract] [Full Text] [Related]

  • 3. Effect of doxazosin GITS on blood pressure in hypertensive and normotensive patients: a review of hypertension and BPH studies.
    Lund-Johansen P, Kirby RS.
    Blood Press Suppl; 2003 May; 1():5-13. PubMed ID: 12800982
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of doxazosin gastrointestinal therapeutic system on patients with uncontrolled hypertension: the ASOCIA Study.
    de Alvaro F, Hernández-Presa MA, ASOCIA Study.
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):271-6. PubMed ID: 16495766
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Profile of doxazosin in the hypertensive man with benign prostatic hyperplasia.
    Kirby RS.
    Br J Clin Pract Suppl; 1994 May; 74():23-8. PubMed ID: 7519438
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Patients with uncontrolled hypertension or concomitant hypertension and benign prostatic hyperplasia.
    Zusman R.
    Clin Cardiol; 2004 Feb; 27(2):63-9. PubMed ID: 14979621
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of doxazosin in the gastrointestinal therapeutic system formulation versus doxazosin standard and placebo in mild-to-moderate hypertension. Doxazosin Investigators' Study Group.
    Os I, Stokke HP.
    J Cardiovasc Pharmacol; 1999 May; 33(5):791-7. PubMed ID: 10226868
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Rahardjo D, Soebadi DM, Sugandi S, Birowo P, Djati W, Wahyudi I.
    Int J Urol; 2006 Nov; 13(11):1405-9. PubMed ID: 17083392
    [Abstract] [Full Text] [Related]

  • 19. Doxazosin for benign prostatic hyperplasia: long-term efficacy and safety in hypertensive and normotensive patients. The Multicenter Study Group.
    Lepor H, Kaplan SA, Klimberg I, Mobley DF, Fawzy A, Gaffney M, Ice K, Dias N.
    J Urol; 1997 Feb; 157(2):525-30. PubMed ID: 8996348
    [Abstract] [Full Text] [Related]

  • 20. Doxazosin in the current treatment of hypertension.
    Wykretowicz A, Guzik P, Wysocki H.
    Expert Opin Pharmacother; 2008 Mar; 9(4):625-33. PubMed ID: 18312163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.